CQV Past Earnings Performance
Past criteria checks 1/6
CQV's earnings have been declining at an average annual rate of -8.7%, while the Chemicals industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 2.8% per year. CQV's return on equity is 4.4%, and it has net margins of 6.7%.
Key information
-8.7%
Earnings growth rate
-7.8%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | 2.8% |
| Return on equity | 4.4% |
| Net Margin | 6.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Returns On Capital At CQV (KOSDAQ:101240) Have Hit The Brakes
Apr 19
These 4 Measures Indicate That CQV (KOSDAQ:101240) Is Using Debt Extensively
Mar 08If You Had Bought CQV (KOSDAQ:101240) Stock Three Years Ago, You Could Pocket A 35% Gain Today
Feb 08Should You Use CQV's (KOSDAQ:101240) Statutory Earnings To Analyse It?
Jan 13Will CQV (KOSDAQ:101240) Multiply In Value Going Forward?
Dec 21
These 4 Measures Indicate That CQV (KOSDAQ:101240) Is Using Debt Extensively
Nov 30Revenue & Expenses BreakdownBeta
How CQV makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 51,101 | 3,425 | 8,933 | 2,524 |
| 30 Sep 23 | 48,588 | 2,048 | 8,621 | 2,200 |
| 30 Jun 23 | 47,413 | 3,057 | 8,558 | 2,177 |
| 31 Mar 23 | 46,064 | 5,052 | 8,676 | 1,822 |
| 31 Dec 22 | 46,285 | 5,384 | 8,579 | 1,843 |
| 30 Sep 22 | 44,219 | 5,932 | 8,572 | 1,884 |
| 30 Jun 22 | 41,017 | 4,349 | 8,387 | 1,881 |
| 31 Mar 22 | 40,066 | 3,436 | 8,062 | 1,860 |
| 31 Dec 21 | 40,002 | 3,514 | 8,103 | 1,796 |
| 30 Sep 21 | 39,653 | 3,934 | 7,908 | 1,911 |
| 30 Jun 21 | 38,702 | 3,170 | 7,694 | 2,029 |
| 31 Mar 21 | 37,187 | 3,213 | 7,562 | 2,256 |
| 31 Dec 20 | 36,972 | 3,648 | 7,282 | 2,456 |
| 30 Sep 20 | 39,194 | 3,500 | 7,719 | 2,445 |
| 30 Jun 20 | 41,343 | 5,178 | 8,053 | 2,436 |
| 31 Mar 20 | 44,493 | 5,938 | 8,321 | 2,345 |
| 31 Dec 19 | 44,747 | 5,945 | 8,347 | 2,296 |
| 30 Sep 19 | 43,260 | 6,188 | 8,111 | 2,270 |
| 30 Jun 19 | 43,189 | 5,656 | 8,022 | 2,430 |
| 31 Mar 19 | 41,915 | 5,099 | 8,203 | 2,601 |
| 31 Dec 18 | 41,389 | 4,504 | 8,100 | 2,600 |
| 30 Sep 18 | 40,817 | 4,067 | 8,121 | 2,688 |
| 30 Jun 18 | 41,208 | 4,452 | 7,989 | 2,846 |
| 31 Mar 18 | 41,181 | 4,318 | 7,847 | 2,760 |
| 31 Dec 17 | 40,172 | 3,786 | 7,803 | 2,853 |
| 30 Sep 17 | 40,920 | 5,273 | 7,696 | 2,820 |
| 30 Jun 17 | 38,767 | 4,075 | 7,647 | 2,616 |
| 31 Mar 17 | 38,318 | 4,027 | 7,525 | 2,554 |
| 31 Dec 16 | 37,880 | 4,860 | 7,168 | 2,499 |
| 30 Sep 16 | 35,285 | 2,920 | 6,778 | 2,443 |
| 30 Jun 16 | 35,232 | 4,112 | 6,482 | 2,368 |
| 31 Mar 16 | 32,435 | 3,542 | 5,997 | 2,312 |
| 31 Dec 15 | 30,644 | 3,008 | 5,725 | 2,231 |
| 30 Sep 15 | 30,377 | 3,719 | 5,608 | 2,089 |
| 30 Jun 15 | 29,352 | 3,202 | 5,411 | 1,948 |
| 31 Mar 15 | 30,226 | 3,361 | 5,238 | 1,921 |
| 31 Dec 14 | 29,771 | 3,356 | 5,219 | 1,811 |
| 30 Sep 14 | 29,097 | 2,842 | 5,062 | 1,893 |
| 30 Jun 14 | 28,240 | 2,124 | 5,083 | 1,869 |
| 31 Mar 14 | 28,105 | 2,162 | 5,089 | 1,905 |
| 31 Dec 13 | 28,083 | 2,467 | 5,068 | 1,969 |
| 30 Sep 13 | 27,907 | 2,961 | 5,045 | 2,064 |
| 30 Jun 13 | 27,145 | 3,056 | 4,835 | 1,987 |
Quality Earnings: A101240 has high quality earnings.
Growing Profit Margin: A101240's current net profit margins (6.7%) are lower than last year (11.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A101240's earnings have declined by 8.7% per year over the past 5 years.
Accelerating Growth: A101240's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A101240 had negative earnings growth (-36.4%) over the past year, making it difficult to compare to the Chemicals industry average (-17.6%).
Return on Equity
High ROE: A101240's Return on Equity (4.4%) is considered low.